Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Information was received from Sanofi Pasteur (manufacturer control # 2016010903) as part of a business agreement on 28-OCT-2016. This case was received from the RA on 26-OCT-2016 under the reference number GB-MHRA-ADR 23693153. Case received from a consumer/other non health professional. A 15-year-old female adolescent patient received GARDASIL, (batch number unknown) via parenteral route on 24-MAR-2014, GARDAIL, (batch number unknown) via parenteral route on 28-JUL-2014. The patient received concomitant administration of: -Baclofen on an unknown date, -Azithromycin on an unknown date, -Lansoprazole on an unknown date. The patient was firstly bed ridden after second was told this was unusual (onset date 24-MAR-2014). She also experienced Epstein-Barre virus infection and post viral fatigue syndrome on an unknown date. The patient had a medical history of immunodeficiency common variable. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166